News Alerts


2013 NYC Hepatitis B & C Surveillance Report NYC Health Department, Feburary 2015. To view click here See also NYC Health Department Online Data Portal EpiQuery. Click here                    

OAKLAND, January 26, 2015 – The Association of Asian Pacific Community Health Organizations (AAPCHO), today launched new a website highlighting stories of Asian Americans and Pacific Islanders (AAPIs) impacted by hepatitis B. The #justB website was created to bring more attention to hepatitis B and the impact it has on the Asian American community, as well as […]

WE ARE PLEASED TO ANNOUNCE THE RELEASE OF THE AWARD-WINNING DOCUMENTARY, THE FIX! THE FIX is a tale of recovery and redemption that paints a powerful portrait of life after heroin addiction in the Bronx. To rent or purchase, head to the following platforms: iTunes | Amazon | Google Play | Vudu | xBox | […]

The NYS Department of Health Drug Utilization Review Board (DURB) has added Harvoni to the NYS Medicaid Fee-for-service formulary. This is an expected outcome since the November 20th approval of Harvoni by the NYS DURB. Below is an excerpt from a letter by Colleen Flanigan, Director of Viral Hepatitis at the NYS Dept. of Health.   As […]

Viral Hep Coordinators are Vital! CDC Blog

January 12, 2015 | Comments Off

Dr. John Ward, Director of the Division of Viral Hepatitis at the Centers for Disease Control and Prevention, authored an article entitled “Viral Hepatitis Prevention Coordinators, a Vital CDC Program Helping to Achieve the Goals of the Viral Hepatitis Action Plan” at on January 9th. The Viral Hepaitits Prevention Coordinators (VHPCs) program began in […]

FDA Approves Viekira Pak to Treat Hep C

December 19, 2014 | Comments Off

A new hepatitis C medication, Viekira Pak, was approved today by the U.S. Food and Drug Administration (FDA). AbbVie, who markets the drug, has not immediately released the price of the new all-oral Hep C medication which will now rival Harvoni and Sovaldi from Gilead Sciences. Harvoni and Sovaldi have generated controversy over their high-price tags and […]

New Regional Board Members Our Executive Board is vital to the governance of the Alliance and, crucially, to provide representation for our patient groups on a regional level. Following a largely contested election, we are happy to now announce our new Regional Board Members for 2014-2016. Our voting members have spoken and votes have been […]

Update 12/15/14: The meeting summary is now available. Outcome of the HARVONI clinical criteria review at the New York State Drug Utilization Review Board (DURB) meeting on November 20th, 2014. The NYS DURB has decided that the newly approved HCV medication Harvoni will use the same Medicaid clinical criteria approved for Solvadi in October, 2014. The criteria includes prioritization […]

Olysio has been approved by the FDA, in combination with Sovaldi, for the treatment of Hepatitis C. It is substantially more expensive than Harvoni; although it depends on treatment time, a 12-week Harvoni treatment costs $94,500, compared to the Olysio-Sovaldi 12-week tag of $150,360. Olysio in combination with Sovaldi is the second Hepatitis C combination treatment regimen […]

AASLD Poster | Check Hep C: A Community Based Approach to HCV Diagnosis in High Risk Populations Check Hep C was implemented in 2012-2013 by the New York City Department of Health and Mental Hygiene (DOHMH) as a year-long demonstration project designed to increase screening, diagnosis, and linkage to care for persons chronically infected with […]

 Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000-2010. Epidemiol Infect. 2014 Nov. Bushnell G, Stennis NL, Drobnik AM, Proops DC, Ahuja SD, Bornschlegel K, Fuld J. Abstract SUMMARY Literature surrounding the burden of and factors associated with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in […]

An evaluation of duplicate Hep C antibody testing conducted by NYC Department of Health staff has been published in the latest issue of Public Health Reports, Volume 129, Number 6, November/December 2014. ABSTRACT Repeating a hepatitis C virus antibody test for a person who previously tested positive provides no new information, wastes resources, and may reflect poor […]

Update 12/15/14: Click here for results of the 11/20/14 NYS DURB meeting. The next NYSDOH Drug Utilization Review (DUR) Board meeting is scheduled for November 20, 2014 in Albany. View info on the meeting on the NYS DOH website. A link to the full meeting agenda can be found here. Harvoni will be presented at this meeting. Public […]

LIVER CANCER CAMPAIGN comes to New York City!The American Liver Foundation (ALF) has announced a special educational campaign commemorating October as Liver Cancer Awareness Month. Sponsored by Bayer and Onyx Pharmaceuticals, the campaign features vibrant, eye catching ads on New York City taxis, subways and buses! The ads urge people at risk for liver cancer to […]

Overview: CMS has finalized its decision to reimburse for HCV screening in primary care settings, for individuals who are Medicare eligible and either “high risk” or born between 1945-1965. “High risk” is defined as persons with a current or past history of illicit injection drug use; and persons who have a history of receiving a blood transfusion […]

Today, the FDA approved Harvoni, a fixed-dose combination pill of ledipasvir and sofosbuvir produced by Gilead Sciences, Inc. The following information was released by the FDA along with the approval. The complete product label will be available soon at DailyMed or at Drugs@FDA. Also see: FDA Press Release on the approval, and Harvoni Patient Information     On October […]

2014 NYC Hep C Research Consortium Report

October 2, 2014 | Comments Off

The 2014 NYC HCV Research Consortium was held at The Rockefeller University on September 29, 2014. The consortium brought together providers, researchers, and community advocates to discuss the current state of hepatitis C research and practice in New York City and determine future priorities. Please review materials and presentations from the consortium below. We will […]

White House Initiative | Launch

September 26, 2014 | Comments Off

The White House Initiative on Asian Americans and Pacific Islanders and are launching a new federal website that aims to consolidate data on the Asian American, Native Hawaiian, and Pacific Islander community:

Global Access to Gilead Hep B Meds

August 19, 2014 | Comments Off

List of countries where individuals can access Gilead medication for HBV; this is in response for those who are on medication and traveling abroad for 3 months or longer.​ ———————————- ASIA Approved: Bangladesh, Bhutan, Cambodia, China, Taiwan, Hong Kong, India, Iran, Israel,  Kazakhstan, Kyrgyzstan, Laos, Myanmar, Pakistan, Saudi Arabia, Singapore, South Korea, Syria, Taiwan, Thailand, Timor, UAE, […]

See original post here. Presidential Proclamation — World Hepatitis Day, 2014 WORLD HEPATITIS DAY, 2014 – – – – – – – BY THE PRESIDENT OF THE UNITED STATES OF AMERICA A PROCLAMATION Around the world, one in twelve people are living with viral hepatitis. In the United States, millions of Americans are infected with […]

New! NYC Department of Health City Health Information (CHI) on Hep C 2014   The Diagnosing and Managing Hepatitis C CHI provides a thorough summary of risk assessment, testing recommendations, laboratory tests, and managing current HCV infection. There is specific information on how providers should speak to patients currently infected with HCV, as well as tables detailing common HCV […]

The New York City Department of Health and Mental Hygiene is currently completing the first segment of a project that aims to gather support for the hepatitis B birth dose in New York City. The overall project will encourage hospitals and birthing centers to adopt a universal hepatitis B birth dose policy, as well as guide […]

Summary: The NYC Department of Health has announced the receipt of a new grant from the Federal government to improve treatment for hepatitis C. The grant will allow the Health Department, in conjunction with the Fund for Public Health in New York, Mount Sinai School of Medicine, Montefiore Medical Center, Weill Cornell Medical College, VNSNY Choice […]

Film | Bronx Premiere of “The Fix”

July 23, 2014 | Comments Off

  The Albert Einstein College of Medicine Division of Substance of Abuse invites you to the Bronx Premiere of “The Fix”! Friday, September 5th   THE FIX – THE HEALING IS MUTUAL By Laura Naylor Winner of the Jury Prize for Best Documentary at the 2014 SOHO International Film Festival, The FIX follows the story […]

NYC Hepatitis B Awareness Week Press Release   The Council of the City of New York Office of Communications City Hall New York, NY 10007 July 21, 2014 Contact: Sam Spokony [Chin]: 212-788-7259, Jefferey LeFrancois [Johnson]: 212-564-7757, Jonathan Chung [Koo]: 718-888-8747, COUNCIL MEMBERS CHIN, JOHNSON AND KOO JOIN HEALTHCARE PROVIDERS AND ADVOCATES […]

« older posts